Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARIA trial of aliskiren added to ramipril plus volume intervention in non-diabetic nephropathy
NL-OMON21705Recruiting
- Sponsor
- Novartis
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of aliskiren in Non-diabetic nephropathy, sponsored by Novartis. Primary endpoint: Albuminuria. Started Jan 2011; status: recruiting.
02
Drugs
aliskiren
03
Conditions
Non-diabetic nephropathy
Beyond the preview
Go deeper on NL-OMON21705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21705.